Integrity Life Sciences Submits FDA Clearance Application for New Version of Spinal Care System

 
Integrity Life Sciences announced it has submitted an application for an additional 510(k) clearance from the U.S. Food and Drug Administration for the newest version of the Integrity Spinal Care System.

Advertisement

Integrity Life Sciences was initially issued FDA clearance for the Integrity Spinal Care System — a non-surgical medical device that applies therapeutic distraction forces to a patient’s spinal column to alleviate low back and neck pain for numerous spinal disorders. The newest version of the system will directly and exclusively target the low back region or lumbar spine.

More Articles on Devices:

Is Biomet Next to Form IPO?
Bioventus Names VP of Global Marketing
Aurora Spine Appoints New VP of Sales

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Stryker CEO Kevin Lobo’s total compensation was $21.4 million in 2025, according to a recent Securities and Exchange Commission proxy filing.…

  • John DeFord, PhD, is stepping down from Globus Medical’s board of directors, according to a March 23 news release. His…

Advertisement

Comments are closed.